Aptus Capital Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.39M Buy
73,769
+48,814
+196% +$4.68M 0.05% 303
2025
Q4
$2.4M Sell
24,955
-1,476
-6% -$143K 0.02% 416
2025
Q3
$2.52M Sell
26,431
-5,532
-17% -$509K 0.02% 396
2025
Q2
$2.79M Buy
31,963
+1,600
+5% +$136K 0.02% 369
2025
Q1
$2.73M Buy
30,363
+2,184
+8% +$195K 0.03% 357
2024
Q4
$2.27M Buy
28,179
+16,679
+145% +$1.44M 0.02% 380
2024
Q3
$1.04M Buy
11,500
+1,487
+15% +$125K 0.02% 403
2024
Q2
$788K Buy
10,013
+1,774
+22% +$145K 0.01% 426
2024
Q1
$718K Buy
8,239
+1,729
+27% +$148K 0.01% 446
2023
Q4
$536K Buy
6,510
+756
+13% +$57.6K 0.01% 371
2023
Q3
$451K Buy
5,754
+2,901
+102% +$243K 0.01% 403
2023
Q2
$251K Sell
2,853
-160
-5% -$13.8K 0.01% 444
2023
Q1
$245K Buy
3,013
+84
+3% +$6.85K 0.01% 428
2022
Q4
$228K Sell
2,929
-32
-1% -$2.59K 0.01% 456
2022
Q3
$242K Buy
2,961
+682
+30% +$61.3K 0.01% 412
2022
Q2
$206K Sell
2,279
-49,457
-96% -$5.01M 0.01% 370
2022
Q1
$5.74M Buy
51,736
+7,427
+17% +$785K 0.14% 94
2021
Q4
$4.58M Buy
44,309
+6,325
+17% +$732K 0.14% 102
2021
Q3
$4.76M Buy
37,984
+7,689
+25% +$995K 0.12% 89
2021
Q2
$3.76M Buy
30,295
+1,084
+4% +$136K 0.11% 97
2021
Q1
$3.45M Buy
29,211
+813
+3% +$95.3K 0.12% 91
2020
Q4
$3.33M Buy
28,398
+4,091
+17% +$450K 0.15% 90
2020
Q3
$2.53M Buy
24,307
+518
+2% +$52K 0.13% 100
2020
Q2
$2.18M Buy
+23,789
New +$2.28M 0.14% 102

Other funds holding MDT

Aptus Capital Advisors's MDT Position: Q1 2026 in Review

Aptus Capital Advisors increased its Medtronic (MDT) stake by 196% in Q1 2026, buying an estimated $4.68M and bringing the position to 73,769 shares worth $6.39M. The position accounts for 0.05% of the portfolio, ranked #303.

Aptus Capital Advisors first reported a position in MDT in Q2 2020 and has held it in 24 quarters since. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Aptus Capital Advisors held 73,769 shares of Medtronic worth $6.39M as of Q1 2026.
  • Aptus Capital Advisors bought 48,814 Medtronic shares in Q1 2026, an estimated $4.68M.
  • Medtronic made up 0.05% of Aptus Capital Advisors's portfolio in Q1 2026, its #303 holding.
  • Aptus Capital Advisors first reported a position in Medtronic in Q2 2020 and has held it in 24 quarters since.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Aptus Capital Advisors's 13F filing for Q1 2026, filed 11 May 2026.